One Year Sustainability of Risk Factor Change from a 9-Week Workplace Intervention

Table 4

Blood biochemistry at baseline (week 0) and follow-up (week 52) for 39 subjects.

	Week 0		Week 52		^†P
	Mean	±SD	Mean	±SD	time	sex	time × sex
Total cholesterol, mmol/L	5.6	±1.1	5.3	±1.0	<.001	.20	.82
LDL cholesterol, mmol/L	3.6	±1.0	3.2	±0.9	<.001	.07	.91
HDL cholesterol, mmol/L	1.44	±0.34	1.47	±0.31	.26	.06	.50
Total cholesterol /HDL	4.10	±1.11	3.76	±0.97	<.001	.001	.29
Triglyceride, mmol/L	1.2	±0.5	1.3	±0.5	.68	.05	.06
Glucose, mmol/L	5.2	±0.4	5.0	±0.4	.01	.39	.59
Insulin, pmol/L	59	±29	50	±26	.005	.52	.023
HOMA B%	93	±30	90	±27	.25	.28	.09
HOMA S%	110	±48	128	±51	.02	.76	.05
AOA (μmol/L)	1213	±429	1320	±372	.03	.36	.81
TBAR (mmol/L)	1.79	±0.24	1.83	±0.25	.06	.08	.87

^†P values for repeated measures ANOVA with sex as fixed effect: HOMA homeostatic model assessment, AOA antioxidant activity, TBAR thiobarbituric acid reactive substances.